Hepatitis C virus infection in dialysis patients
- 1 July 2007
- journal article
- review article
- Published by Wiley in Hemodialysis International
- Vol. 11 (3), 286-295
- https://doi.org/10.1111/j.1542-4758.2007.00181.x
Abstract
Hepatitis C virus (HCV) infection is a global health problem, common worldwide, leading to acute and chronic hepatitis and its consequences of hepatocirrhosis and hepatocellular carcinoma. Patients on hemodialysis belong to the high-risk group of HCV infection. The prevalence of HCV infection in dialysis patients ranges from 4% to more than 70% in some countries. The main reasons for such a high incidence of infections are a high prevalence of HCV infection in the general population, lack of standard infection precautions and effective vaccination, inadequate disinfection procedures of dialysis machines and other medical equipment, as well as spread of infection from patient to patient, especially in dialytic centers with a high percentage of infected patients. The diagnostic procedures useful in the evaluation of HCV infection are detection of anti-HCV antibodies, identification of HCV RNA, counts of virus copies, and identification of its genome. From the 6 major genotypes and multiple subtypes of the HCV, genotypes 1a and 1b are the most common in Europe and Japan, and 1b is responsible for more severe liver disease and aggressive course leading to liver fibrosis. Antiviral therapy of HCV+ dialysis patients with interferon-alpha (INF-alpha) gives slightly better results than in the general population, but is poorly tolerated and associated with side effects. Although ribavirin in not recommended for dialysis patients, the addition of small doses of this compound to pegylated INF is discussed, especially for patients in whom previous infection treatment failed.Keywords
This publication has 94 references indexed in Scilit:
- Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPSKidney International, 2004
- Risk of death and liver cirrhosis in anti‐HCV‐positive long‐term haemodialysis patientsNephrology Dialysis Transplantation, 2001
- HCV liver disease in renal transplantation: a clinical and histological studyNephrology Dialysis Transplantation, 1996
- Immunological disorders in C virus chronic hepatitisNephrology Dialysis Transplantation, 1996
- Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritisNephrology Dialysis Transplantation, 1996
- Type I membranoproliferative glomerulonephritis and HCV infectionNephrology Dialysis Transplantation, 1996
- Epidemiology of HCV infection in the general population and in blood transfusionNephrology Dialysis Transplantation, 1996
- Natural history of hepatitis C virus infectionNephrology Dialysis Transplantation, 1996
- End stage renal disease and dialysis reportNephrology Dialysis Transplantation, 1996
- Differences in the hepatitis C virus genotypes in different countriesJournal of Hepatology, 1993